Posts tagged with ‘marine drugs’

  • Mar. Drugs, Volume 13, Issue 12 (December 2015), Pages 7055-7475 Released

    MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 12 (December 2015), Pages 7055-7475   Table of Contents Special Issue Marine Secondary Metabolites Article: Mycosporine-Like Amino Acids Promote Wound Healing through Focal Adhesion Kinase (FAK) and Mitogen-Activated Protein Kinases (MAP Kinases) Signaling Pathway in Keratinocytes by Yun-Hee Choi, Dong Joo Yang, Atul Kulkarni, […]
    0
  • Mar. Drugs, Volume 13, Issue 11 (November 2015), Pages 6550-7054 Released

    MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 11 (November 2015), Pages 6550-7054   Table of Contents Special Issue Green Chemistry Approach to Marine Products Article: Purification and Characterization of Cathepsin B from the Muscle of Horse Mackerel Trachurus japonicus by Asami Yoshida, Megumi Ohta, Koichi Kuwahara, Min-Jie Cao, Kenji Hara and Kiyoshi […]
    0
  • Seaweed extract fucoidan could treat inflammation of the gut, research finds

    Tasmanian research has found a seaweed extract could be the key to combating inflammatory bowel disorders. Bowel disorders such as ulcerative colitis can be debilitating and lead to a significantly decreased quality of life. The breakthrough findings showed seaweed extract, taken orally, significantly reduced the symptoms of the disorders in animal testing. The extract is called fucoidan, a polysaccharide extracted from the […]
    0
  • Mar. Drugs, Volume 13, Issue 6 (June 2015), Pages 3259-3991 Released

    MDPI us pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 6 (June 2015), Pages 3259-3991   Table of Contents Special Issue Marine Peptides and Their Mimetics Article: Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreusTargeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes by Shuo Wang, Cong Zhao, Zhuguo Liu, Xuesong Wang, […]
    0
  • Marine Drugs: Mar. Drugs, Volume 13, Issue 2 (February 2015), Pages 697-1083 Available

    MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 2 (February 2015), Pages 697-1083. More info Table of Contents Special Issue Marine Anti-infective Agents Article: Sulphated Polysaccharides from Ulva clathrata and Cladosiphon okamuranus Seaweeds both Inhibit Viral Attachment/Entry and Cell-Cell Fusion, in NDV Infection by José Alberto Aguilar-Briseño, Lucia Elizabeth Cruz-Suarez, Jean-François Sassi, Denis Ricque-Marie, Pablo […]
    0
  • Mar. Drugs, Volume 13, Issue 1 (January 2015), Pages 1-696 Released

    MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 1 (January 2015), Pages 1-696 Table of Contents Special Issue Marine Anti-infective Agents Article: Marine-Derived Quorum-Sensing Inhibitory Activities Enhance the Antibacterial Efficacy of Tobramycin against Pseudomonas aeruginosa by Alessandro Busetti, George Shaw, Julianne Megaw, Sean P. Gorman, Christine A. Maggs and Brendan F. Gilmore Mar. Drugs 2015, 13(1), […]
    0
  • Mar. Drugs, Volume 12, Issue 9 (September 2014), Pages 4713-5088 — Now Available

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 12, Issue 9 (September 2014), Pages 4713-5088 http://www.mdpi.com/1660-3397/12/9/
    0
  • Odyssey Marine Exploration and Morphogenesis discover biotech ‘treasures’ in the deep

    Researchers at biotech firm Morphogenesis have identified marine microorganisms that will yield critical pharmaceuticals such as anti-cancer drugs and antibiotics from seafloor sediment samples harvested by Odyssey. Morphogenesis Inc., a leading biotechnology and cancer-treatment research and development firm, has discovered substances with pharmaceutical properties beneficial to mankind from seafloor sediment samples that were recovered from the ocean bottom by Odyssey Marine […]
    0
  • First Transnational Joint Call for Research Projects: Marine Biotechnology ERA-NET

    Announcing the first transnational joint call for research projects within the framework of the Marine Biotechnology ERA-NET (ERA-MarineBiotech), which aims to coordinate European funding for marine biotechnology research, development and innovation. The main purpose of the call is to stimulate joint European research and development activities in marine biotechnology. The topic of the first transnational call is “The development of biorefinery processes […]
    0
  • Agile Nabs $1.5M NIH Grant for CF Therapy from Sea Sponge

    Raleigh biotechnology company Agile Sciences has landed a $1.5 million National Institutes of Health grant to help develop its cystic fibrosis therapy derived from sea sponges. Agile was spun out of North Carolina State University with the help of a $30,000 startup loan from the North Carolina Biotechnology Center. The company’s technology platform capitalizes on a chemical produced by the sea sponge to […]
    0